Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)‐6 produced during remission phase

Por Barros, P. O., Cassano, T., Hygino, J., Ferreira, T. B., Centurião, N., Kasahara, T. M., Andrade, R. M., Linhares, U. C., Andrade, A. F. B., Vasconcelos, C. C. F., Alvarenga, R., Marignier, R., Bento, C. A. M.
Publicado no Clin Exp Immunol (2015)

Interleukin‐17‐ and interleukin‐22‐secreting myelin‐specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients

Por Wing, Ana Cristina, Hygino, Joana, Ferreira, Thais B., Kasahara, Taissa M., Barros, Priscila O., Sacramento, Priscila M., Andrade, Regis M., Camargo, Solange, Rueda, Fernanda, Alves‐Leon, Soniza V., Vasconcelos, Claudia Cristina, Alvarenga, Regina, Bento, Cleonice A. M.
Publicado no Immunology (2015)

Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis

Por Ferreira, Thais B, Hygino, Joana, Barros, Priscila O, Teixeira, Bruna, Kasahara, Taissa M, Linhares, Ulisses C, Lopes, Lana Márcia F, Vasconcelos, Claudia Cristina F, Alvarenga, Regina, Wing, Ana Cristina, Andrade, Regis M, Andrade, Arnaldo F B, Bento, Cleonice A M
Publicado no Immunology (2014)